Risks include: Age: Older folks might not absorb B12 as well
Food and Drug Administration (FDA) has issued warning letters to manufacturers selling some of these compounds as supplements
Key considerations for B12 intravenous dosing include: Initial dose: 1,000 mcg per infusion Frequency of administration: varies based on clinical need Monitoring of patient response to adjust dosing as necessary IV Infusion Methods and Duration B12 IV infusions are given slowly to avoid side effects
Effective dosing ranged between 0.25 and 2.0 mg/kg/day ( The serotonergic 5-HT 4 receptor agonist, cisapride, was associated with symptomatic benefit in patients with gastroparesis based on short-or medium-term placebo-controlled trials (Richards et al., 1993a), and on long-term, open-label studies ( Other medications available in a few countries, clebopride, cinitapride, and mosapride, are not reviewed in detail here in view of the relatively weak evidence of efficacy in gastroparesis
Are other chronic diseases involved
Cracked glass can introduce glass particles into the solution